CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 28 filers reported holding CLOVIS ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,515,000 | +137775.0% | 5,130,000 | +128150.0% | 0.00% | – |
| Q1 2018 | $4,000 | -99.9% | 4,000 | -99.9% | 0.00% | -100.0% |
| Q4 2017 | $5,542,000 | -0.6% | 4,119,000 | +13.8% | 0.00% | 0.0% |
| Q3 2017 | $5,577,000 | +322.2% | 3,619,000 | +363.4% | 0.00% | +300.0% |
| Q2 2017 | $1,321,000 | +13.3% | 781,000 | -13.9% | 0.00% | 0.0% |
| Q1 2017 | $1,166,000 | -34.5% | 907,000 | -47.7% | 0.00% | 0.0% |
| Q4 2016 | $1,781,000 | +88.5% | 1,734,000 | +73.4% | 0.00% | 0.0% |
| Q3 2016 | $945,000 | +33.9% | 1,000,000 | 0.0% | 0.00% | – |
| Q2 2016 | $706,000 | +4.1% | 1,000,000 | -0.1% | 0.00% | -100.0% |
| Q1 2016 | $678,000 | -58.1% | 1,001,000 | -47.1% | 0.00% | 0.0% |
| Q4 2015 | $1,617,000 | +99.4% | 1,892,000 | +289.3% | 0.00% | 0.0% |
| Q3 2015 | $811,000 | – | 486,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 70,125,000 | $118,981,000 | 5.01% |
| PFM Health Sciences, LP | 46,790,999 | $79,428,000 | 2.14% |
| Partner Investment Management, L.P. | 790,001 | $1,341,000 | 1.80% |
| Myriad Asset Management Ltd. | 10,000,000 | $16,984,000 | 1.18% |
| CSS LLC/IL | 10,950,000 | $18,558,000 | 0.90% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 9,074,000 | $15,403,000 | 0.42% |
| SSI INVESTMENT MANAGEMENT LLC | 2,784,000 | $4,715,000 | 0.42% |
| ZAZOVE ASSOCIATES LLC | 4,030,000 | $6,833,000 | 0.36% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,826,000 | $13,277,000 | 0.25% |
| LORD, ABBETT & CO. LLC | 18,243,000 | $30,967,000 | 0.09% |